Although initial clinical trials of tamoxifen as a treatment for breast cancer were positive, its development was nearly halted by concerns over commercial viability.
Dora Richardson and her boss Arthur Walpole continued their research on tamoxifen in secret after ICI decided to cancel its development, believing in its life-saving potential.
Tamoxifen eventually launched in the U.K. in 1973 and became a global success, significantly impacting breast cancer treatment and saving hundreds of thousands of lives.
Despite her crucial role in synthesizing tamoxifen, Dora Richardson's contributions were largely overshadowed by her male colleagues, leaving her story mostly forgotten.
Collection
[
|
...
]